Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Utilization of social media communities for caregiver information support in stroke recovery: An analysis of content and interactions

Lobo EH, Johnson T, Frølich A, Kensing F, Rasmussen LJ, Hosking SM, Page AT, Livingston PM, Islam SMS, Grundy J, Abdelrazek M

(2022), PLoS One, 17(1), e0262919

DOI: 10.1371/journal.pone.0262919

Management of dental emergencies amongst Australian general medical practitioners - A case-vignette study

Park JS, Page AT, Shen PH, Price K, Tennant M, Kruger E

(2022), Aust Dent J, 67(1), 30-8

DOI: 10.1111/adj.12878

Medication use to manage comorbidities for people with dementia: A systematic review

Kate Wang, Ajanine Alan, Amy Page, Mia Percival, Christopher Etherton-Beer

(2022), Journal of Pharmacy Practice and Research, 52(3), 161-79

DOI: 10.1002/jppr.1802

Dementia-Like Symptoms Associated With Posaconazole

Corallo CE, Ivulich SP, Kotecha DS, Morrissey O

(2022), Journal of pharmacy practice, 35(1), 135-9

DOI: 10.1177/0897190020958235

Safety and Pharmacokinetics of LHF-535, a Potential Treatment for Lassa Fever, in Healthy Adults

Amberg S, Snyder B, Vliet-Gregg P, Tarcha E, Posakony J, Bedard K, Heald A

(2022), ANTIMICROB AGENTS CH, 66(11), e0095122

DOI: 10.1128/aac.00951-22

Adverse drug reaction management in hospital settings: Review on practice variations, quality indicators, and education focus

Aung AK, Walker S, Khu YL, Tang MJ, Lee JI, Graudins LV

(2022), Eur J Clin Pharmacol, 78(5), 781-791

DOI: 10.1007/s00228-022-03287-1

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)

James F, Goh MSY, Mouhtouris E, Vogrin S, Chua KYL, Holmes NE, Awad A, Copaescu AM, De Luca JF, Zubrinich C, Gin D, Cleland H, Douglas A, Kern JS, Katelaris CH, Thien F, Barnes S, Yun J, Tong W, Smith WB, Carr A, Anderson T, Legg A, Bourke J, Mackay LK, Aung AK, Phillips EJ, Trubiano J

(2022), BMJ Open, 12(8), e055906

DOI: 10.1136/bmjopen-2021-055906

Research activities in general medicine: a scoping survey by the Internal Medicine Society of Australia and New Zealand

Aung AK, Pickles R, Knight A, Shannon LA, Bowers A, Donnelly S, Johnson DF, Scott IA, Potter EL

(2022), Intern Med J, 52(9), 1505-1512

DOI: 10.1111/imj.15866

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Loo S, Dillon R, Ivey A, Anstee NS, Othman J, Tiong IS, Potter N, Jovanovic J, Runglall M, Chong CC, Bajel A, Ritchie D, Yeoh ZH, McBean M, Gilkes A, Thomas I, Johnson S, Russell N, Wei A

(2022), Blood, 140(22), 2407-11

DOI: 10.1182/blood.2022016567

Hypertension in thyroid disease and primary hyperparathyroidism

Szwarcbard N Topliss DJ

(2022), In: Pappachan JM, Fernandez CJ (Editors) Endocrine Hypertension: From Basic Science to Clinical Practice Elsevier, New York, 249-261

Classification and laboratory diagnosis of diabetes mellitus

Hare MJL, Topliss DJ

(2022), In: Bandeira F, Gharib H, Griz L, Faria M (eds) Endocrinology and Diabetes – a problem oriented approach 2nd Edition Springer, New York,

A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care

Silva C, Catapan S, Bird D, Clemensen J, Janda M, Fatehi F, Menon A , Russell A

(2022), DIABETIC MED, 39(9), e14886

DOI: 10.1111/dme.14886

Corneal dendritic cell dynamics are associate with clinical factors in Type 1 diabetes

Luisa H Colorado, Lauren Beecher, Nicola Prichard, Khaled Al Rashah, Cirous Dehghani, Anthony Russell, Rayaz A Malik, Nathan Efron, Katie Edward

(2022), J CLIN MED, 11(9), 2611

DOI: 10.3390/jcm11092611.

Thyroid hormone replacement therapy in hypothyroidism

Rosi L, Topliss DJ

(2022), Endocrinology Today, 11, 31-35

Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis

Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators

(2022), DIABETES CARE, 45(12), 2991-8

DOI: 10.2337/dc22-0294

Letter to the Editor From Danek et al: "Environmental Pollution, Climate Change, and a Critical Role for the Endocrinologist"

Danek E, Blackburn D, Topliss DJ, Sztal-Mazer S

(2022), J CLIN ENDOCR METAB, 107(9), e3964

DOI: 10.1210/clinem/dgac351

Applying the TIRADS categorization for thyroid nodules in practice

Ng E, Topliss DJ

(2022), Endocrinology Today, 11, 32-5

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

Wirth LJ, Durante C, Topliss DJ, Winquist E, Robenshtok E, Iwasaki H, Luster M, Elisei R, Leboulleux S, Tahara M

(2022), Oncologist, 27(7), 565-72

DOI: 10.1093/oncolo/oyac065

Q-122 as a novel non-hormonal oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blinded, placebo-controlled trial

Vrselja A, Latifi A, Baber RJ, Stuckey BGA, Walker MG, Stearns V, Hickey M, Davis SR

(2022), Lancet, 400(10364), 1704-11

DOI: 10.1016/S0140-6736(22)01977-8

Treating menopause - MHT and beyond

Davis SR, Baber R

(2022), NAT REV ENDOCRINOL, 18(8), 490-502

DOI: 10.1038/s41574-022-00685-4

54 55 56 57 58